Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 78.02M | 69.83M | 65.12M | 53.03M | 39.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.02M | 69.83M | 65.12M | 53.03M | 39.42M |
| Cost of Revenue | 35.95M | 32.17M | 29.24M | 23.77M | 17.85M |
| Gross Profit | 42.08M | 37.66M | 35.89M | 29.26M | 21.57M |
| SG&A Expenses | 73.79M | 63.80M | 54.96M | 48.41M | 39.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 140.55M | 124.27M | 110.38M | 93.62M | 77.81M |
| Operating Income | -62.53M | -54.44M | -45.25M | -40.58M | -38.39M |
| Income Before Tax | -73.37M | -70.96M | -54.76M | -55.50M | -54.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -73.37 | -70.96 | -54.76 | -55.50 | -54.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.37M | -70.96M | -54.76M | -55.50M | -54.44M |
| EBIT | -62.53M | -54.44M | -45.25M | -40.58M | -38.39M |
| EBITDA | -61.34M | -53.30M | -44.13M | -39.40M | -37.20M |
| EPS Basic | -5.59 | -7.57 | -8.71 | -9.12 | -9.28 |
| Normalized Basic EPS | -3.50 | -4.73 | -5.44 | -5.70 | -5.80 |
| EPS Diluted | -5.59 | -7.57 | -8.71 | -9.12 | -9.28 |
| Normalized Diluted EPS | -3.50 | -4.73 | -5.44 | -5.70 | -5.80 |
| Average Basic Shares Outstanding | 87.04M | 49.75M | 25.06M | 24.42M | 23.22M |
| Average Diluted Shares Outstanding | 87.04M | 49.75M | 25.06M | 24.42M | 23.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |